GSK President announces his departure

GlaxoSmithKline‘s President, Philip Hampton,  has announced his departure a month after the British pharmaceutical group unveiled its plan to create a joint venture with Pfizer to become a leader in non-prescription drugs.

Read AGEFI’s full article in French

Read the Financial Times full article in English